Literature DB >> 8783493

The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy.

T Soussi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783493     DOI: 10.1016/0167-5699(96)30019-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  15 in total

1.  p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.

Authors:  Hala E Hamouda; Soha S Zakaria; Saber A Ismail; Mahmoud A Khedr; Wael W Mayah
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  The history of p53. A perfect example of the drawbacks of scientific paradigms.

Authors:  Thierry Soussi
Journal:  EMBO Rep       Date:  2010-10-08       Impact factor: 8.807

3.  Humoral immune response to p53 in malignant glioma.

Authors:  M Weller; A Bornemann; M Ständer; M Schabet; J Dichgans; R Meyermann
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

4.  Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.

Authors:  P Hainaut; T Soussi; B Shomer; M Hollstein; M Greenblatt; E Hovig; C C Harris; R Montesano
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

5.  Targeted tumor cell death induced by autologous tumor-specific T lymphocyte recognition of wild-type p53-derived peptides.

Authors:  Hideo Tsurushima; Yoshihiko Yoshii; Kam W Leong; Tadao Ohno
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 6.  Features of autoantigens.

Authors:  W H Reeves; M Satoh
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 7.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 8.  [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Authors:  T K Hoffmann; T L Whiteside; H Bier
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

Review 9.  Lymphoproliferation in autoimmunity and Sjögren's syndrome.

Authors:  Michalis Voulgarelis; Haralampos M Moutsopoulos
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 10.  T cell-tumor interaction directs the development of immunotherapies in head and neck cancer.

Authors:  A E Albers; L Strauss; T Liao; T K Hoffmann; A M Kaufmann
Journal:  Clin Dev Immunol       Date:  2010-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.